The Department of the Army Medical Command has awarded a $440,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to Baylor College of Medicine in Houston, Texas. The grant, which runs from January 15, 2025 to January 14, 2027, will fund research on "Biopolymers for Intestinal Healing and Immune Modulation to Treat Inflammatory Bowel Disease." As a leading academic medical institution, Baylor College of Medicine has a strong track record of...
The Department of the Army Medical Command awarded Baylor College of Medicine a $10,087,552 project grant from the Military Medical Research and Development program (CFDA 12.420) for the period of July 1, 2022 to June 30, 2026. The grant funds research on combinatorial helper-dependent adenoviral gene therapy for post-traumatic osteoarthritis. Specifically, Baylor College of Medicine and sub-awardees Cornell University ($401,517 each) will conduct preclinical studies to assess the prevention...
The U.S. Department of the Army Medical Command awarded a $170,202 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant aims to "COMPARING COGNITIVE BEHAVIORAL THERAPY AND ACUPUNCTURE FOR MANAGING CHRONIC PAIN (COMBAT-PAIN)" with a performance period from September 30, 2024 to December 31, 2025. As part of this Project Grant, The University of...
The Department of the Army Medical Command awarded Baylor College of Medicine a $320,000 project grant under the Military Medical Research and Development program (CFDA 12.420) for the period of March 1, 2022 through February 29, 2024. The grant will support research into the anti-fibrotic effects of macropinocytosis inhibition in idiopathic pulmonary fibrosis. Through the Military Medical Research and Development program, the Department of the Army aims to transform military and public health...
Baylor College of Medicine was awarded a $3.67 million Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The four-year award will support research investigating KCA1.1 ion channels in synovial fibroblasts. Through this funding, Baylor College of Medicine researchers aim to advance understanding of medical solutions for battlefield injuries and transform military and public health care. The place of performance for this work...
The U.S. Defense Health Agency awarded Baylor College of Medicine a $896,645.00 Project Grant on May 15, 2024 under the Military Medical Research and Development program (CFDA 12.420). This grant supports research to investigate thromboinflammation in rheumatoid arthritis, with a performance period from May 2024 to May 2028. As part of this project, Baylor College of Medicine has provided $28,061 in sub-grant funding to the University of Houston System to construct and characterize wild-type and...
This federal Project Grant award, totaling $1,496,576.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant will fund advanced biomedical research at Baylor College of Medicine in Houston, Texas, focused on transforming healthcare for military service members and the broader public. The research aims to advance disease prevention, diagnosis, treatment, and management through basic, applied, and translational research...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $2,500,000.00 to Baylor University to conduct a multisite, multigroup non-inferiority randomized clinical trial on "Conservative Care for Pelvic Pain (C2P2) in Women Service Members." The 4-year award, which begins on September 1, 2024 and ends on August 31, 2028, aims to develop clinical decision tools for conservative care...
This $839,745 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) aims to improve care and outcomes for veterans with post-traumatic epilepsy. The grant was awarded to Baylor College of Medicine, a private health sciences university in Houston, Texas, to conduct research and develop new treatments in this area over the 3-year performance period from May 1, 2024 to April 30, 2027. As a leading academic medical center, Baylor...
The Baylor College of Medicine will receive $1,193,609 through September 29, 2025 from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the Roles of Mechanosensitive Channels in Pressure Wave-Induced Retinal Damage. This Project Grant will support Baylor College of Medicine's investigation into medical solutions for the battlefield by exploring the molecular and cellular mechanisms by which pressure...